David Emerson Jorden, CEO, CFO at Nuo Therapeutics, Inc. (AURX), bought 247,500 shares at $0.22 ($54K) on 2017-08-10, disclosed to the SEC on 2017-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |
| CMXI | BUY | 2013-05-21 | $40K | — | Filing → |